Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Express Scripts
Colorcon
Boehringer Ingelheim
Moodys

Last Updated: November 26, 2022

CLINICAL TRIALS PROFILE FOR WELCHOL


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Welchol

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00147719 ↗ WelChol® With Metformin in Treating Patients With Type 2 Diabetes Completed Daiichi Sankyo Inc. Phase 3 2004-06-01 The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to metformin alone or in combination with other anti-diabetic drugs.
NCT00147719 ↗ WelChol® With Metformin in Treating Patients With Type 2 Diabetes Completed Daiichi Sankyo, Inc. Phase 3 2004-06-01 The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to metformin alone or in combination with other anti-diabetic drugs.
NCT00147745 ↗ Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes Completed Daiichi Sankyo Inc. Phase 2 2005-06-01 This study is designed to assess the potential mechanism of action by which WelChol® (colesevelam) may improve blood glucose control in patients with type 2 diabetes
NCT00147745 ↗ Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes Completed Daiichi Sankyo, Inc. Phase 2 2005-06-01 This study is designed to assess the potential mechanism of action by which WelChol® (colesevelam) may improve blood glucose control in patients with type 2 diabetes
NCT00147758 ↗ WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes Completed Daiichi Sankyo Inc. Phase 3 2004-06-01 The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to sulfonylurea alone or in combination with other anti-diabetic drugs.
NCT00147758 ↗ WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes Completed Daiichi Sankyo, Inc. Phase 3 2004-06-01 The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to sulfonylurea alone or in combination with other anti-diabetic drugs.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Welchol

Condition Name

Condition Name for Welchol
Intervention Trials
Type 2 Diabetes 7
Type 2 Diabetes Mellitus 5
Hypercholesterolemia 5
Hyperlipidemia 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Welchol
Intervention Trials
Diabetes Mellitus, Type 2 13
Diabetes Mellitus 10
Hypercholesterolemia 5
Insulin Resistance 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Welchol

Trials by Country

Trials by Country for Welchol
Location Trials
United States 243
Peru 4
Mexico 4
Canada 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Welchol
Location Trials
California 16
Florida 14
Ohio 12
Minnesota 12
Texas 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Welchol

Clinical Trial Phase

Clinical Trial Phase for Welchol
Clinical Trial Phase Trials
Phase 4 13
Phase 3 7
Phase 2/Phase 3 1
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Welchol
Clinical Trial Phase Trials
Completed 25
Unknown status 1
Recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Welchol

Sponsor Name

Sponsor Name for Welchol
Sponsor Trials
Daiichi Sankyo Inc. 20
Daiichi Sankyo, Inc. 20
Mayo Clinic 5
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Welchol
Sponsor Trials
Industry 48
Other 14
NIH 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Baxter
Boehringer Ingelheim
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.